Sentinel node biopsy in melanoma: The experience of Brescia Civic Hospital

The accuracy of the sentinel node (SN) technique in the evaluation of lymph node involvement in melanoma was evaluated in 71 consecutive patients with localized disease and Breslow index >1 mm. Lymphoscintigraphy identified a t least one SN in 70 of the 71 patients (98.5%). The following day 69 patie nts underwent selective SN excision. The SN was identified by portable prob e. One hundred and twenty-two lymph nodes were removed, 14 (11.4%) of which were metastatic in 9 patients (13%). No metastases were found in 40 patien ts with Breslow <2 mm. Eight of the 9 patients with positive SNs underwent lymphadenectomy of the whole basin and in two patients new metastatic nodes were found. At 4-26 months' with negative SN (scalp follow-up 1 of the 60 patients with negative SN (scalp melanoma with Breslow 6.2 mm) developed bi lateral cervical metastatic nodes. Two more patients with Breslow 3.7 and 5 mm, respectively, developed liver and lung metastases. The remaining 57 pa tients are still disease free. Among the 9 patients with tumor-positive SNs , 1 was lost to follow-up, 3 died and 5 are still alive. Our data confirm t he clinical reliability of the SN technique in melanoma; we feel the techni que should be considered a standard tool in the evaluation of melanoma pati ents.